These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 24073806

  • 1. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M.
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
    Szilágyi E, Füzi M, Böröcz K, Kurcz A, Tóth A, Nagy K.
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
    Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M.
    Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [Abstract] [Full Text] [Related]

  • 10. Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
    Marra AR, Pereira CA, Castelo A, do Carmo Filho JR, Cal RG, Sader HS, Wey SB.
    Int J Infect Dis; 2006 Jan; 10(1):56-60. PubMed ID: 16326126
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases.
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-León A, Sifuentes-Osornio J.
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O, Schechner V, Carmeli Y, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Molina J, Hernández-Torres A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Navarro-San Francisco C, Bonomo RA, Paterson DL, Pascual A, Rodríguez-Baño J, REIPI/ESGBIS/INCREMENT investigators.
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [Abstract] [Full Text] [Related]

  • 15. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
    Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, Fadda G, Cauda R.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):498-504. PubMed ID: 16436702
    [Abstract] [Full Text] [Related]

  • 16. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC.
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [Abstract] [Full Text] [Related]

  • 17. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H, Wei J, Zhou W, Yan X, Cao X, Zuo L, Chen S, Yao K, Huang R, Chen Y, Wu C.
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [Abstract] [Full Text] [Related]

  • 18. A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.
    Tanır Basaranoglu S, Ozsurekci Y, Aykac K, Karadag Oncel E, Bıcakcigil A, Sancak B, Cengiz AB, Kara A, Ceyhan M.
    Ital J Pediatr; 2017 Sep 12; 43(1):79. PubMed ID: 28899399
    [Abstract] [Full Text] [Related]

  • 19. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    Xiao T, Zhu Y, Zhang S, Wang Y, Shen P, Zhou Y, Yu X, Xiao Y.
    J Infect Dis; 2020 Mar 16; 221(Suppl 2):S174-S183. PubMed ID: 32176799
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
    Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.
    Clin Infect Dis; 2004 Jul 01; 39(1):31-7. PubMed ID: 15206050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.